Article
Oncology
Sun Gui Feng, Rajeev Bhandari, Liu Ya, Bian Zhixuan, Pan Qiuhui, Zhu Jiabei, Mao Sewi, Zhen Ni, Wang Jing, Sun Fenyong, Ma Ji, Ramesh Bhandari
Summary: The study revealed that SNHG9 is upregulated in hepatoblastoma, with its overexpression promoting cell proliferation and colony formation, while knockdown inhibiting these activities. Various experimental methods confirmed the interaction between SNHG9, miR-23a-5p, and Wnt3a, highlighting its significant role in hepatoblastoma.
Article
Oncology
Tomoaki Irie, Daiki Yoshii, Yoshihiro Komohara, Yukio Fujiwara, Masashi Kadohisa, Masaki Honda, Shinya Suzu, Toshiharu Matsuura, Kenichi Kohashi, Yoshinao Oda, Taizo Hibi
Summary: This study aimed to investigate the potential roles of macrophages in hepatoblastoma. The findings revealed significant differences in the number of macrophages among different histological subtypes. In vitro experiments showed that conditioned medium from hepatoblastoma cell lines induced increased CD163 expression in macrophages, and direct co-culture with macrophages induced tumor cell proliferation. Additionally, overexpression of IL-34 in embryonal components promoted tumor cell proliferation and chemoresistance.
Article
Cell Biology
Ramesh Bhandari, Imran Ibrahim Shaikh, Rajeev Bhandari, Sadikchha Chapagain
Summary: This study reveals the important role of LINC01023 in the development of hepatoblastoma and suggests that it could be a potential therapeutic target and prognostic biomarker in hepatoblastoma.
MOLECULAR AND CELLULAR BIOCHEMISTRY
(2023)
Review
Cell Biology
Zijun Xie, Chenming Zhong, Shiwei Duan
Summary: miR-1269a and miR-1269b play important roles in the occurrence and development of multiple cancers. They have the potential to be diagnostic and prognostic markers for cancer. Further research can focus on elucidating more upstream and downstream genes and exploring the clinical application value of miR-1269a and miR-1269b.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Zhouguang Wu, Siqi Chen, Taoyan Zuo, Jingru Fu, Jiafeng Gong, Dong Liu, Bin Wang
Summary: Through qPCR, we found differential expression of five candidate tumor suppressor miRNAs in hepatoblastoma (HB). We investigated the regulatory mechanism of the target miRNA molecule and its effect on invasion and migration in HB cells. Bioinformatics analysis revealed that miR-139-3p may target Wnt5A to regulate the WNT pathway, which was confirmed by further assays. This suggests that miR-139-3p and Wnt5A could be potential targets for HB treatment.
MOLECULAR BIOTECHNOLOGY
(2023)
Article
Entomology
Linhong Li, Bin Zhu, Xi Sun, Kaiwen Zheng, Pei Liang, Xiwu Gao
Summary: This study characterized the toxicological properties of miR-34-5p, a lepidopteran microRNA, and found that it has insecticidal effects on multiple lepidopteran pests. These results suggest that miRNAs can serve as novel molecular targets for controlling lepidopteran pests.
JOURNAL OF PEST SCIENCE
(2023)
Article
Biochemistry & Molecular Biology
Matjaz Rokavec, Zekai Huang, Heiko Hermeking
Summary: This study conducted a comprehensive integrative meta-analysis of multiple computational and experimental miR-34 related datasets, and developed tools to identify and characterize novel miR-34 targets. The meta-analysis results were integrated into a user-friendly website, METAmiR34TARGET, which allows for the prediction of relevant miR-34 targets using expression data obtained from cell lines and tumors/tissues. The website also includes information on more than 200 experimentally validated miR-34 target mRNAs. This research is important for further understanding the role of the p53/miR-34 connection in tumor suppression and for identifying potential cancer drug targets.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
(2023)
Article
Oncology
Chen Zheng, Shiru Ye, Wei Liu, Mei Diao, Long Li
Summary: This study evaluated the prognostic value of preoperative inflammatory indexes in pediatric hepatoblastoma patients receiving neoadjuvant chemotherapy. The results showed that a high inflammatory index was associated with a lower 5-year survival rate. SIRI was identified as an independent prognostic factor for hepatoblastoma patients. A nomogram model based on SIRI, POSTTEXT staging, MiVI, and AFP was constructed to predict the prognosis of these patients.
FRONTIERS IN ONCOLOGY
(2023)
Article
Pediatrics
Tian Zhi, Wei-Ling Zhang, Yi Zhang, Hui-Min Hu, Dong-Sheng Huang
Summary: This study aimed to summarize the clinical characteristics of hepatoblastoma in children under 3 years old and analyze factors affecting prognosis. The results showed that factors such as AFP level, platelet count, PRETEXT staging, vascular invasion, and distant metastasis were independent risk factors for the prognosis of children with hepatoblastoma.
Article
Biochemistry & Molecular Biology
Matthias Bache, Frauke Kadler, Olivia Struck, Daniel Medenwald, Christian Ostheimer, Antje Guettler, Jacqueline Kessler, Matthias Kappler, Anne Riemann, Oliver Thews, Barbara Seliger, Dirk Vordermark
Summary: The concentration of miR-16, miR-29a, and miR-144 in the plasma of NSCLC patients undergoing radiotherapy was evaluated, and their impact on patients' prognosis was assessed. The results showed that the plasma levels of miR-16, miR-29a, and miR-144 had prognostic value in NSCLC patients, while the level of miR-150 did not predict prognosis. Patients with low levels of these three miRs in their plasma at the end of radiotherapy had the worst prognosis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Oncology
Tian Zhi, Weiling Zhang, Yi Zhang, Huimin Hu, Dongsheng Huang
Summary: Hepatoblastoma (HB) in infants under one year of age is characterized by abdominal bulging, with a relatively good prognosis but vulnerable to factors such as AFP levels, staging, and metastases.
CANCER MANAGEMENT AND RESEARCH
(2021)
Article
Oncology
Beatriz Sanchez-Sendra, Jose F. Gonzalez-Munoz, Silvia Perez-Deben, Carlos Monteagudo
Summary: This study found that BRAF mutations do not significantly affect the predictive ability of miR-125b, miR-200c, and miR-205. These three miRNAs can independently predict the clinical outcomes of patients with primary melanoma, regardless of BRAF mutational status.
Review
Oncology
Jinze Shen, Yuchen Wu, Wenjing Ruan, Feng Zhu, Shiwei Duan
Summary: MiR-1908 is a miRNA with abnormal expression in many diseases, involved in various biological processes through targeting multiple genes. The expression of miR-1908 is regulated by multiple factors and is associated with the prognosis of several cancers.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Meng Ke, Yan Zhou, Yang Chang-Zhen, Long Li, Mei Diao
Summary: By retrospectively analyzing the clinical data of HBs patients, we constructed a predictive model for the survival outcome in HBs. The model showed good predictive ability with high C-index in both training and validation cohorts. The calibration curve of the model indicated good agreement between the prediction and observation.
PEDIATRIC BLOOD & CANCER
(2022)
Article
Cell Biology
Shuang Wu, Shihai Liu, Yongxian Cao, Geng Chao, Peng Wang, Huazheng Pan
Summary: This study identifies ZC3H13 as a potential tumor suppressor gene in hepatocellular carcinoma (HCC) and reveals the miR-362-3p/miR-425-5p-ZC3H13 axis as a regulatory pathway. The expression of ZC3H13 is closely associated with the prognosis and tumor immune infiltration in HCC.